Relpax Migraine Report Trademark Details

Relpax Migraine Report was registered on Tuesday, September 7, 2004 and is currently owned by Pfizer Inc. under the registration number 2883069 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 13 years ago on Friday, April 8, 2011, according to the United State Patent & Trademark Office
Word Mark Relpax Migraine Report
Status Dead Registered 710 — Cancelled - Section 8
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 78190610
Registration Number 2883069
Status Date Friday, April 8, 2011
Filing Date Friday, April 8, 2011
Registration Date Tuesday, September 7, 2004
Attorney Jane Ungaro

Correspondent

Jane Ungaro
Pfizer Inc.
150 East 42nd Street
New York NY 10017

Case File Statements

Disclaimer with Predetermined Text "Migraine Report"
Goods & Services Printed materials, namely, newsletters, brochures, pamphlets, booklets, leaflets, manuals on the topic of migraines

Classifications

International Class Codes
016 — Class 16 includes mainly paper, goods made from that material and office requisites.
U.S. Class Codes 002, 005, 022, 023, 029, 037, 038, 050
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, April 8, 2011
First Use Anywhere Tuesday, September 30, 2003
First Use In Commerce Tuesday, September 30, 2003
Primary Code 016

You must be signed in to print.

Once signed in, look for the PDF button.